Showing results (1811-1820 of 9,903) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|February 19, 2020
LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantationRoni Shouval, Omer Teper, Joshua A Fein, et al.Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.Bone Marrow Transplantation|March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.Bone Marrow Transplantation|March 12, 2020
Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpointsSagar S Patel, Brittany Lapin, Navneet S Majhail, et al.Bone Marrow Transplantation|March 6, 2020
Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphomaMariana Bastos-Oreiro, Pascual Balsalobre, Pilar Miralles, et al.Bone Marrow Transplantation|January 31, 2020
Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retrospective studyFrancesco Saglio, Marco Zecca, Daria Pagliara, et al.Bone Marrow Transplantation|November 22, 2022
EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Filippo Magri, Laura Giordano, et al.Bone Marrow Transplantation|January 21, 2014
Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problemsL E Cohen, J H Gordon, E Y Popovsky, et al.Bone Marrow Transplantation|May 21, 2014
Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignanciesH-L Liu, Z-M Sun, L-Q Geng, et al.Bone Marrow Transplantation|April 14, 2015
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantationMarina Konopleva, Christopher B Benton, Peter F Thall, et al.Pageof 991